Government of Canada continues to strengthen Canada’s biomanufacturing sector

Mississauga Board of Trade
Mississauga Board of Trade

Published

May 18, 2021

Subscribe

Updates on new members, upcoming events, and the latest news.

"*" indicates required fields

The Government of Canada recognized early in the pandemic that increasing domestic biomanufacturing capabilities was critical. That is why it has been making major investments to rebuild Canada’s biomanufacturing capacity. These investments contribute to breakthrough technology efforts to develop made-in-Canada solutions such as vaccines and treatments for future pandemics and to commercialize made-in-Canada solutions to COVID-19.

Today, the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, announced an investment of $199.16 million in Resilience Biotechnologies Inc.

This investment will support a $401.52-million project that will help develop Canada’s medical countermeasures to COVID-19 and strengthen Canada’s emergency preparedness for future pandemics.

This investment will help Resilience Biotechnologies Inc. increase its manufacturing and fill-finish capacity for a number of vaccines and therapeutics, including for those that use novel technology such as mRNA and that are now being deployed to fight COVID-19. Once completed, the company’s Mississauga facility is expected to allow for the manufacturing of approximately 112 million to 640 million doses of mRNA vaccines per year.

This expansion will further expand Resilience Biotechnologies Inc.’s presence in Canada, with clinical and commercial manufacturing and aseptic fill-finish capabilities for critical vaccines and therapeutics. With this investment, Resilience Biotechnologies Inc. will create and maintain 500 full-time jobs in Canada and create 50 co-op positions.

The government has prioritized growing a vibrant Canadian biomanufacturing and life sciences sector, which is why Budget 2021 proposes a total of $2.2 billion to build on the progress already made toward this goal.

Scroll to Top